Dyfyniad APA

Adamo, B., Ricciardi, G. R. R., Ieni, A., Franchina, T., Fazzari, C., Sanò, M. V., . . . Adamo, V. (2017). The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer. Oncotarget.

Dyfyniad Arddull Chicago

Adamo, Barbara, et al. "The Prognostic Significance of Combined Androgen Receptor, E-Cadherin, Ki67 and CK5/6 Expression in Patients With Triple Negative Breast Cancer." Oncotarget 2017.

Dyfyniad MLA

Adamo, Barbara, et al. "The Prognostic Significance of Combined Androgen Receptor, E-Cadherin, Ki67 and CK5/6 Expression in Patients With Triple Negative Breast Cancer." Oncotarget 2017.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.